Novel COVID-19 vaccine offers superior protection against Omicron variants

The improved response against the BA.1 subvariant was reported on June 6 in the journal Nature Communications. The results of the study involving the BA.2 subvariant were published July 19 in the journal Cell Discovery.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/PBTuzmN
via IFTTT